HS may affect patients with familial Mediterranean fever (FMF), a prototypic monogenic AID, carrying MEFV mutations, with a higher frequency of MEFV mutations reported in HS patients than in healthy controls, suggesting a potential contribution to HS pathogenesis [42,43]. This evidence concerns the gene MEFV and histiocytic sarcoma.